$4.130
-0.154 (-3.73%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
IMDX 相似图表分析预测
Alphio's IMDX stock price prediction model matches the current Insight Molecular Diagnostics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.12 (-0.16%). The 1-week path is $4.43 (+7.15%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Insight Molecular Diagnostics Inc 股票吗?
Insight Molecular Diagnostics Inc (IMDX) appears to be a good buy right now due to its current price of $4.13, which is significantly below the analyst price target of $8, indicating a potential upside of 93.4%. Additionally, the company has a gross margin of 65.69% in Q2 2026, suggesting strong profitability potential as it scales. However, the main risk is the projected cash burn of approximately $8 million in the second half of 2026, which could impact financial stability if not managed effectively.
IMDX 股价于 Friday 收于 $4.13,此前下跌 -3.73%
Insight Molecular Diagnostics Inc (IMDX) last closed at $4.13, losing -3.73%. These facts feed the 1-day and 1-week IMDX price prediction above.
预测驱动因素
Insight Molecular Diagnostics Inc(IMDX)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 IMDX 最接近的股票,按相似度排序。
IMDX 季节性分析
Historically the probability of a positive August return for IMDX is 0.00%. October offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。